Cellular and Tissue Therapies Branch, Division of Cellular and Gene Therapies, Center for Biologics Evaluation and Research, US Food and Drug Administration, Bethesda, Maryland, USA.
Stem Cells. 2015 Jul;33(7):2169-81. doi: 10.1002/stem.1967. Epub 2015 May 26.
Bone marrow-derived multipotent stromal cells (BM-MSCs) display a broad range of therapeutically valuable properties, including the capacity to form skeletal tissues and dampen immune system responses. However, to use BM-MSCs in a clinical setting, amplification is required, which may introduce epigenetic changes that affect biological properties. Here we used chromatin immunoprecipitation to compare post-translationally modified histones at a subset of gene promoters associated with developmental and environmental plasticity in BM-MSCs from multiple donors following culture expansion. At many locations, we observed localization of both transcriptionally permissive (H3K4me3) and repressive (H3K27me3) histone modifications. These chromatin signatures were consistent among BM-MSCs from multiple donors. Since promoter activity depends on the relative levels of H3K4me3 and H3K27me3, we examined the ratio of H3K4me3 to H3K27me3 (K4/K27) at promoters during culture expansion. The H3K4me3 to H3K27me3 ratios were maintained at most assayed promoters over time. The exception was the adipose-tissue specific promoter for the PPAR-γ2 isoform of PPAR-γ, which is a critical positive regulator of adipogenesis. At PPAR-γ2, we observed a change in K4/K27 levels favoring the repressed chromatin state during culture. This change correlated with diminished promoter activity in late passage cells exposed to adipogenic stimuli. In contrast to BM-MSCs and osteoblasts, lineage-restricted preadipocytes exhibited levels of H3K4me3 and H3K27me3 that favored the permissive chromatin state at PPAR-γ2. These results demonstrate that locus-specific changes in H3K4me3 and H3K27me3 levels can occur during BM-MSC culture that may affect their properties. Stem Cells 2015;33:2169-2181.
骨髓间充质干细胞(BM-MSCs)表现出广泛的治疗价值,包括形成骨骼组织和抑制免疫系统反应的能力。然而,要在临床环境中使用 BM-MSCs,需要扩增,这可能会引入影响生物学特性的表观遗传变化。在这里,我们使用染色质免疫沉淀技术比较了来自多个供体的 BM-MSCs 中与发育和环境可塑性相关的一组基因启动子的翻译后修饰组蛋白,这些细胞在培养扩增后。在许多位置,我们观察到转录允许(H3K4me3)和抑制(H3K27me3)组蛋白修饰的定位。这些染色质特征在来自多个供体的 BM-MSCs 之间是一致的。由于启动子活性取决于 H3K4me3 和 H3K27me3 的相对水平,我们在培养扩增过程中检查了启动子处 H3K4me3 与 H3K27me3 的比值(K4/K27)。随着时间的推移,大多数检测到的启动子的 H3K4me3 与 H3K27me3 比值保持不变。例外的是 PPAR-γ 的 PPAR-γ2 同工型的脂肪组织特异性启动子,PPAR-γ 是脂肪生成的关键正调控因子。在 PPAR-γ2 中,我们观察到 K4/K27 水平的变化有利于培养过程中抑制染色质状态。这种变化与暴露于成脂刺激的晚期传代细胞中启动子活性的降低相关。与 BM-MSCs 和成骨细胞不同,谱系限制的前脂肪细胞表现出有利于 PPAR-γ2 中允许染色质状态的 H3K4me3 和 H3K27me3 水平。这些结果表明,在 BM-MSC 培养过程中,H3K4me3 和 H3K27me3 水平的特定基因座变化可能会影响它们的特性。干细胞 2015;33:2169-2181.